Summit Therapeutics Inc. (SMMT)

Every figure this model derived for SMMT, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2024-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 0 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 690,678,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 720,578,000 AssetsCurrent 2026-06-30
current liabilities 103,566,000 LiabilitiesCurrent 2026-06-30
equity 629,983,000 StockholdersEquity 2026-06-30
interest expense 0 InterestExpenseNonoperating 2025-12-31
revenue 0 RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31
sbc 0 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up SMMT on one particular measure came for.

RatioValue
current ratio6.96
current ratio reported6.96
dilution pct4.06
growth cv6.65

What to be careful about

What this model itself distrusts about SMMT's figures. Written by the derivation as it ran, not added afterwards.